G9a/GLP-dependent histone H3K9me2 patterning during human hematopoietic stem cell lineage commitment

Genes and Development

Volumn 26, Issue 22, 2012, Pages 2499-2511

  Chen, Xiaoji ^a   Skutt Kakaria, Kyobi ^a,b   Davison, Jerry ^a   Ou, Yang Li ^a   Choi, Edward ^a   Malik, Punam ^c   Loeb, Keith ^a   Wood, Brent ^d   Georges, George ^a   Torok Storb, Beverly ^a   Paddison, Patrick J ^a  

^a USA   (United States)

^b EVERGREEN STATE COLLEGE   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d SEATTLE CANCER CARE ALLIANCE   (United States)

Author keywords

Differentiation; G9a; GLP; H3K9me2; Hematopoietic stem and progenitor cell; UNC0638

Indexed keywords

2 CYCLOHEXYL N (1 ISOPROPYL 4 PIPERIDINYL) 6 METHOXY 7 [3 (1 PYRROLIDINYL)PROPOXY] 4 QUINAZOLINAMINE; G9A PROTEIN; GLP PROTEIN; HISTONE H3; HISTONE H3 LYSINE 9; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL NUCLEUS; CELL SPECIFICITY; CHROMATIN; CHROMATIN STRUCTURE; CPG ISLAND; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ADULT; ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; CHROMATIN; CPG ISLANDS; DNA METHYLATION; DOGS; ENZYME INHIBITORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEMATOPOIETIC STEM CELLS; HISTOCOMPATIBILITY ANTIGENS; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; MICE; QUINAZOLINES;

MAMMALIA;

EID: 84869162797     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.200329.112     Document Type: Article

References (55)

1. Akashi K, He X, Chen J, Iwasaki H, Niu C, Steenhard B, Zhang J, Haug J, Li L. 2003. Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis. Blood 101: 383-389.
2. Akinsheye I, Alsultan A, Solovieff N, Ngo D, Baldwin CT, Sebastiani P, Chui DH, Steinberg MH. 2011. Fetal hemoglobin in sickle cell anemia. Blood 118: 19-27.
3. Attema JL, Papathanasiou P, Forsberg EC, Xu J, Smale ST, Weissman IL. 2007. Epigenetic characterization of hematopoietic stem cell differentiation using miniChIP and bisulfite sequencing analysis. Proc Natl Acad Sci 104: 12371-12376.
4. Bauer DE, Orkin SH. 2011. Update on fetal hemoglobin gene regulation in hemoglobinopathies. Curr Opin Pediatr 23: 1-8.
5. Baum CM, Weissman IL, Tsukamoto AS, Buckle AM, Peault B. 1992. Isolation of a candidate human hematopoietic stemcell population. Proc Natl Acad Sci 89: 2804-2808.
6. Beck DB, Oda H, Shen SS, Reinberg D. 2012. PR-Set7 and H4K20me1: At the crossroads of genome integrity, cell cycle, chromosome condensation, and transcription. Genes Dev 26: 325-337.
7. Birkmann J, Oez S, Smetak M, Kaiser G, Kappauf H, Gallmeier WM. 1997. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and earlyacting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium. Stem Cells 15: 18-32.
8. Boitano AE, Wang J, Romeo R, Bouchez LC, Parker AE, Sutton SE, Walker JR, Flaveny CA, Perdew GH, Denison MS, et al. 2010. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 329: 1345-1348.
9. Chaturvedi CP, Hosey AM, Palii C, Perez-Iratxeta C, Nakatani Y, Ranish JA, Dilworth FJ, Brand M. 2009. Dual role for the methyltransferase G9a in the maintenance of b-globin gene transcription in adult erythroid cells. Proc Natl Acad Sci 106: 18303-18308.
10. Cheng T, Rodrigues N, Shen H, Yang Y, Dombkowski D, Sykes M, Scadden DT. 2000. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287: 1804-1808.
11. Cocozza S, Akhtar MM, Miele G, Monticelli A. 2011. CpG islands undermethylation in human genomic regions under selective pressure. PLoS ONE 6: e23156. doi: 10.1371/journal.pone.0023156.
12. Collins R, Cheng X. 2010. A case study in cross-talk: The histone lysine methyltransferases G9a and GLP. Nucleic Acids Res 38: 3503-3511.
13. Collins RE, Northrop JP, Horton JR, Lee DY, Zhang X, Stallcup MR, Cheng X. 2008. The ankyrin repeats of G9a and GLP histone methyltransferases are mono- and dimethyllysine binding modules. Nat Struct Mol Biol 15: 245-250.
14. Cui K, Zang C, Roh TY, Schones DE, Childs RW, Peng W, Zhao K. 2009. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 4: 80-93.
15. Dahlberg A, Delaney C, Bernstein ID. 2011. Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood 117: 6083-6090.
16. Delaney C, Heimfeld S, Brashem-Stein C, Voorhies H, Manger RL, Bernstein ID. 2010. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med 16: 232-236.
17. Doulatov S, Notta F, Laurenti E, Dick JE. 2012. Hematopoiesis: A human perspective. Cell Stem Cell 10: 120-136.
18. Eichler EE, Hoffman SM, Adamson AA, Gordon LA, McCready P, Lamerdin JE, Mohrenweiser HW. 1998. Complex b-satellite repeat structures and the expansion of the zinc finger gene cluster in 19p12. Genome Res 8: 791-808.
19. Estève PO, Chin HG, Smallwood A, Feehery GR, Gangisetty O, Karpf AR, Carey MF, Pradhan S. 2006. Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication. Genes Dev 20: 3089-3103.
20. Feldman N, Gerson A, Fang J, Li E, Zhang Y, Shinkai Y, Cedar H, Bergman Y. 2006. G9a-mediated irreversible epigenetic inactivation of Oct-3/4 during early embryogenesis. Nat Cell Biol 8: 188-194.
21. Gardiner-Garden M, Frommer M. 1987. CpG islands in vertebrate genomes. J Mol Biol 196: 261-282.
22. Gaspar-Maia A, Alajem A, Meshorer E, Ramalho-Santos M. 2011. Open chromatin in pluripotency and reprogramming. Nat Rev Mol Cell Biol 12: 36-47.
23. Georges GE, Lesnikov V, Baran SW, Aragon A, Lesnikova M, Jordan R, Laura Yang YJ, Yunusov MY, Zellmer E, Heimfeld S, et al. 2010. A preclinical model of double- versus singleunit unrelated cord blood transplantation. Biol Blood Marrow Transplant 16: 1090-1098.
24. Graf L, Iwata M, Torok-Storb B. 2002. Gene expression profiling of the functionally distinct human bone marrow stromal cell lines HS-5 and HS-27a. Blood 100: 1509-1511.
25. Gyory I, Wu J, Fejer G, Seto E, Wright KL. 2004. PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing. Nat Immunol 5: 299-308.
26. Hodges E, Molaro A, Dos Santos CO, Thekkat P, Song Q, Uren PJ, Park J, Butler J, Rafii S, McCombie WR, et al. 2011. Directional DNA methylation changes and complex intermediate states accompany lineage specificity in the adult hematopoietic compartment. Mol Cell 44: 17-28.
27. Hu M, Krause D, Greaves M, Sharkis S, Dexter M, Heyworth C, Enver T. 1997. Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev 11: 774-785.
28. Ikegami K, Iwatani M, Suzuki M, Tachibana M, Shinkai Y, Tanaka S, Greally JM, Yagi S, Hattori N, Shiota K. 2007. Genome-wide and locus-specific DNA hypomethylation in G9a deficient mouse embryonic stem cells. Genes Cells 12: 1-11.
29. Kim JK, Estève PO, Jacobsen SE, Pradhan S. 2009. UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells. Nucleic Acids Res 37: 493-505.
30. Kolasinska-Zwierz P, Down T, Latorre I, Liu T, Liu XS, Ahringer J. 2009. Differential chromatin marking of introns and expressed exons by H3K36me3. Nat Genet 41: 376-381.
31. Kubicek S, O'Sullivan RJ, August EM, Hickey ER, Zhang Q, Teodoro ML, Rea S, Mechtler K, Kowalski JA, Homon CA, et al. 2007. Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol Cell 25: 473-481.
32. Litt MD, Simpson M, Gaszner M, Allis CD, Felsenfeld G. 2001. Correlation between histone lysine methylation and developmental changes at the chicken b-globin locus. Science 293: 2453-2455.
33. Majeti R, Park CY, Weissman IL. 2007. Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. Cell Stem Cell 1: 635-645.
34. Månsson R, Hultquist A, Luc S, Yang L, Anderson K, Kharazi S, Al-Hashmi S, Liuba K, Thoren L, Adolfsson J, et al. 2007. Molecular evidence for hierarchical transcriptional lineage priming in fetal and adult stem cells and multipotent progenitors. Immunity 26: 407-419.
35. Manz MG, Miyamoto T, Akashi K, Weissman IL. 2002. Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci 99: 11872-11877.
36. Miyamoto T, Iwasaki H, Reizis B, Ye M, Graf T, Weissman IL, Akashi K. 2002. Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. Dev Cell 3: 137-147.
37. Noma K, Allis CD, Grewal SI. 2001. Transitions in distinct histone H3 methylation patterns at the heterochromatin domain boundaries. Science 293: 1150-1155.
38. Notta F, Doulatov S, Laurenti E, Poeppl A, Jurisica I, Dick JE. 2011. Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science 333: 218-221.
39. Novershtern N, Subramanian A, Lawton LN, Mak RH, Haining WN, McConkey ME, Habib N, Yosef N, Chang CY, Shay T, et al. 2011. Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell 144: 296-309.
40. O'Geen H, Echipare L, Farnham PJ. 2011. Using ChIP-seq technology to generate high-resolution profiles of histone modifications. Methods Mol Biol 791: 265-286.
41. - cord blood cells. J Clin Invest 110: 1165-1174.
42. Orkin SH, Zon LI. 2008. Hematopoiesis: An evolving paradigm for stem cell biology. Cell 132: 631-644.
43. Ostrander EA, Giniger E. 1997. Semper fidelis: What man's best friend can teach us about human biology and disease. Am J Hum Genet 61: 475-480.
44. Peters AH, Kubicek S, Mechtler K, O'Sullivan RJ, Derijck AA, Perez-Burgos L, Kohlmaier A, Opravil S, Tachibana M, Shinkai Y, et al. 2003. Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Mol Cell 12: 1577-1589.
45. Rice JC, Briggs SD, Ueberheide B, Barber CM, Shabanowitz J, Hunt DF, Shinkai Y, Allis CD. 2003. Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol Cell 12: 1591-1598.
46. Roopra A, Qazi R, Schoenike B, Daley TJ, Morrison JF. 2004. Localized domains of G9a-mediated histone methylation are required for silencing of neuronal genes. Mol Cell 14: 727-738.
47. Sauvageau G, Iscove NN, Humphries RK. 2004. In vitro and in vivo expansion of hematopoietic stem cells. Oncogene 23: 7223-7232.
48. Saxonov S, Berg P, Brutlag DL. 2006. A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc Natl Acad Sci 103: 1412-1417.
49. Su RC, Brown KE, Saaber S, Fisher AG, Merkenschlager M, Smale ST. 2004. Dynamic assembly of silent chromatin during thymocyte maturation. Nat Genet 36: 502-506.
50. Szilvassy SJ, Humphries RK, Lansdorp PM, Eaves AC, Eaves CJ.1990. Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy. Proc Natl Acad Sci 87: 8736-8740.
51. Tachibana M, Sugimoto K, Nozaki M, Ueda J, Ohta T, Ohki M, Fukuda M, Takeda N, Niida H, Kato H, et al. 2002. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev 16: 1779-1791.
52. Thomas ED, Storb R. 1999. The development of the scientific foundation of hematopoietic cell transplantation based on animal and human studies. In Hematopoietic cell transplantation (ed. ED Thomas et al.), pp. 1-11. Blackwell Science, Malden, MA.
53. Vedadi M, Barsyte-Lovejoy D, Liu F, Rival-Gervier S, Allali-Hassani A, Labrie V, Wigle TJ, Dimaggio PA, Wasney GA, Siarheyeva A, et al. 2011. A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nat Chem Biol 7: 566-574.
54. Wen B, Wu H, Shinkai Y, Irizarry RA, Feinberg AP. 2009. Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat Genet 41: 246-250.
55. Zhang J, Grindley JC, Yin T, Jayasinghe S, He XC, Ross JT, Haug JS, Rupp D, Porter-Westpfahl KS, Wiedemann LM, et al. 2006. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 441: 518-522